Brief: European Patent Office To Approve Corline Biomedical's Renaparin Patents
June 17 (Reuters) - Corline Biomedical AB CLBIO.ST :
* EUROPEAN PATENT OFFICE INTENDS TO APPROVE ADDITIONAL
RENAPARIN
PATENTS
* INTENT TO GRANT LETTER RECEIVED FROM THE EUROPEAN PATENT
OFFICE
TO GRANT THE COMPANY PATENT APPLICATION P9346EP1
* PATENT APPLICATION COVERS CORLINE'S TECHNOLOGY TO PROCESS
AND
PROTECT BLOOD VESSELS IN ORGANS FOR TRANSPLANTATION AND IN THE
DIRECT TREATMENT OF PATIENT
Source text for Eikon: ID:nGNE3tqbh1
Further company coverage: CLBIO.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Corline Biomedical AB
See all newsBrief: Corline Biomedical Expectes Positive EBITDA In 2027
Brief: Corline Biomedical: Canada To Grant Kardium Up To C$31.25 Mln For Manufacturing Capacity Expansion
Brief: Corline Biomedical Q2 Net Sales Amount To SEK 4.7 Million
Brief: Corline Biomedical Partner Kardium Receives Approval For Globe Pulsed Field System In Canada
Brief: Corline Biomedical Q1 Result After Financial Items At SEK -2.5 Mln